Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Journal of Pain Research|October 17, 2017
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerationsPiero Barbanti, Patrizia Ferroni
Frontiers in Neurology|August 28, 2020
Botulinum Neurotoxin for the Treatment of Neuropathic PainGabriella Egeo, Luisa Fofi, Piero Barbanti
Expert Review of Neurotherapeutics|August 7, 2007
Sumatriptan fast-disintegrating/rapid-release tablets in the acute treatment of migrainePiero Barbanti, Domenica Le Pera, Giorgio Cruccu
Headache|September 12, 2019
Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?Piero Barbanti, Gabriella Egeo, Dimos D Mitsikostas
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 30, 2019
Does the migraine attack start in the cortex and is the cortex critical in the migraine process?Piero Barbanti, Luisa Fofi, Cinzia Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 23, 2013
Dopaminergic symptoms in migrainePiero Barbanti, L Fofi, C Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 31, 2012
Future trends in drugs for migraine prophylaxisPiero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Functional Neurology|April 5, 2003
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist testGiovanni Fabbrini, Piero Barbanti, Cinzia Aurilia, et al.
Pageof 11